Skip to main content
. Author manuscript; available in PMC: 2012 Jan 3.
Published in final edited form as: Arch Gen Psychiatry. 2006 Oct;63(10):1121–1129. doi: 10.1001/archpsyc.63.10.1121

Table 1.

Outcome Indices for Patients Treated With Scopolamine Hydrobromide*

Baseline Block Block 1 Block 2
P/S group (n = 10)
 CGI-I scale score (vs baseline)
  1–2 0 0 9
  3 3 2 1
  4 5 6 0
  5–6 2 2 0
 Full response (>50%) 0 0 7
 Partial response (24%–49%) 0 0 3
 Remission (MADRS score ≤10) 0 0 6
S/P group (n = 8)
 CGI-I scale score (vs baseline)
  1–2 0 6 7
  3 2 2 1
  4 4 0 0
  5–6 2 0 0
 Full response (>50%) 0 4 4
 Partial response (25%–49%) 0 2 4
 Remission (MADRS score ≤10) 0 3 4

Abbreviations: CGI-I, Clinical Global Impressions–Improvement; MADRS, Montgomery-Asberg Depression Rating Scale; P/S, placebo/scopolamine; S/P, scopolamine/placebo.

*

Data are given as number of patients.

In the CGI-I scale, 1 indicates very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; and 6, much worse.